taletrectinib
innovent biologics,baoyuan biopharma
['sclc', 'lung', 'taletrectinib', 'nsclc']
excited to present our updated phase 2 data at #asco2022 #ros1 inhibitor #taletrectinib in #nsclc #lungcancer. #brainmets #asco22 read the full release: 
Clinical-stage global oncology company developing novel precision therapies